Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

2.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

3.

healthy despite having advanced cancer.

4.

Breast awareness: What to look for in your self-exam

5.

Significant differences in breast cancer care still exist, but surgeons can change.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot